Jacqueline Howard
Jacqueline Howard is a reporter for CNN Health based in Atlanta, Georgia. She has covered a wide range of health topics including mental health, maternal health, and infectious diseases. Her reporting on the COVID-19 pandemic and maternal mortality rates following childbirth in the United States stood out. Jacqueline also served as senior science editor at The Huffington Post and has experience in various communication fields. She holds a master's degree in journalism from the University of Southern California's Annenberg School for Communication & Journalism and a bachelor's degree in communication studies from the University of Michigan-Ann Arbor.
80%
The Daily's Verdict
This author has a mixed reputation for journalistic standards. It is advisable to fact-check, scrutinize for bias, and check for conflicts of interest before relying on the author's reporting.
Bias
88%
Examples:
- The articles tend to favor the scientific consensus and the recommendations of health organizations such as the CDC.
Conflicts of Interest
75%
Examples:
- There is a potential conflict of interest in the article about the MPOX vaccine, as it heavily favors the CDC's recommendation without presenting any opposing views or potential drawbacks of the vaccine.
Contradictions
86%
Examples:
- There are minor contradictions in some of the articles regarding cancer incidence and screening recommendations.
Deceptions
75%
Examples:
- Some articles use misleading language or present information that could be perceived as deceptive, such as the article about mental health crisis among healthcare workers.
Recent Articles
FDA Approves First Blood Test, Shield, as Primary Screening Option for Colon and Rectal Cancers: A New Convenient Tool to Detect CRC Early
Broke On: Monday, 29 July 2024The FDA approves Guardant Health's Shield blood test as a primary screening option for colorectal cancer in adults over 45, marking the first approval of its kind. With an 83% sensitivity rate and potential accessibility advantages over colonoscopies, the Shield test could encourage more people to get screened for this second deadliest cancer in the US. 
Lenacapavir Injections Offer 100% Protection Against HIV for Women and Adolescent Girls: A Game-Changer in the Fight Against AIDS
Broke On: Wednesday, 24 July 2024A study reveals that a twice-yearly injection of lenacapavir provides 100% protection against HIV infections among women and adolescent girls, offering a potential game-changer in the fight against the virus. The drug, produced by Gilead Sciences, works by disrupting the protein shells of HIV and is more effective than daily pills for prevention with a lower failure rate. 
One-Third of Older Adults Continue to Use Aspirin for Primary Prevention Despite Increased Bleeding Risk
Broke On: Monday, 24 June 2024Despite updated guidelines discouraging aspirin use for primary cardiovascular disease prevention in older adults due to increased bleeding risk, one-third of adults aged 60 and above without the disease continue to consume it. Recent studies reveal that nearly 3.3 million of these individuals take preventative aspirin without medical advice. The American College of Cardiology, American Heart Association, and U.S. Preventive Services Task Force advise against aspirin use for primary prevention in adults aged 60 and above or those with increased bleeding risk. 
Introducing Peanut Butter in Infancy: A Key Step in Preventing Peanut Allergies
Broke On: Tuesday, 28 May 2024Introducing peanut butter in infancy significantly reduces the risk of developing a peanut allergy later on. Recent studies, including the LEAP and NEJM Evidence research, prove that early exposure to peanuts from infancy to age 5 lowers the risk by up to 71%. 
New AAP Policy: HIV-Positive Mothers Can Safely Breastfeed with Proper Medication and Guidelines
Broke On: Monday, 20 May 2024The American Academy of Pediatrics (AAP) has updated its policy, allowing HIV-positive mothers to breastfeed their babies if they are on effective antiretroviral medication and follow guidelines. This reverses decades-old advice due to the significant reduction in HIV transmission risk via breast milk, now less than 1%. Mothers must exclusively breastfeed for six months and initiate ART early in pregnancy for this approach. 
New First-Trimester Blood Test Offers Promise in Early Detection of Preeclampsia
Broke On: Wednesday, 15 May 2024A new first-trimester blood test, with up to 90% sensitivity and specificity, identifies the risk of preeclampsia in pregnant women. This life-threatening condition, which can lead to complications like high blood pressure and preterm birth, usually develops after 20 weeks. The test allows for earlier intervention between weeks 11 and 14 for high-risk populations, including older women, first-time mothers, those with obesity or a family history of preeclampsia. Regular prenatal care remains essential for a healthy pregnancy. FDA Approves Self-Collection for Cervical Cancer Screening: Expanding Access and Convenience with HPV Tests by Roche and BD
Broke On: Wednesday, 15 May 2024The FDA's approval of self-collection for cervical cancer screening using HPV tests from Roche and BD marks a significant step towards expanding access and convenience. This decision, which could lead to home testing in the future, is expected to increase opportunities for early detection and treatment while reducing barriers for marginalized communities. 
New CDC Rules for Dog Importation: Keeping America Rabies-Free
Broke On: Wednesday, 08 May 2024New CDC rules require all dogs entering the US to be healthy, microchipped, and have a completed online import form. These regulations aim to prevent rabies in America, where the disease was eliminated in dogs in 2007 but still poses a risk from wildlife. 
CRISPR Gene Therapy Restores Vision for 11 of 14 Participants with Inherited Blindness in Landmark Clinical Trial
Broke On: Monday, 06 May 2024A groundbreaking clinical trial led by Mass Eye and Ear's Eric Pierce, MD, Ph.D., has shown promising results in restoring vision for individuals with Leber Congenital Amaurosis (LCA) using CRISPR-Cas9 gene editing. The study demonstrated the safety and effectiveness of EDIT-101 in correcting the CEP290 gene mutation, improving vision for 11 out of 14 participants without serious side effects. This marks a significant milestone in treating inherited blindness using gene editing techniques, with similar results reported from Children's Hospital of Philadelphia and Missouri State University. 
Long Beach, CA: 14 Cases of Tuberculosis Identified in Public Health Emergency
Broke On: Friday, 03 May 2024A public health emergency has been declared in Long Beach, California due to a tuberculosis outbreak that has resulted in 14 cases, nine hospitalizations, and one death. The source of the outbreak is traced back to a single room occupancy hotel where several individuals were infected. The city is collaborating with local and state health departments as well as the CDC to contain the outbreak and ensure those affected receive proper treatment.
